Mary Ann T Banez, MD
Ophthalmology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 34 years
- New York University School of Medicine, 1992
Offices
1 location
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Banez’s office at (415) 285-5180 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$17,599
Medicare paid this office $17,599 for 68 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 33 | $10,898 | $118 |
| Established patient complete exam of visual system | 44 | $3,325 | $68 |
| New patient visit (45+ min) | 14 | $1,437 | $103 |
| Exam of visual field with extended testing | 14 | $345 | $25 |
| Imaging of optic nerve | 17 | $333 | $20 |
Who their Medicare patients are
68 Original Medicare patients in 2024. Average age 78 · 85 and older 29% · Women 68% · Also on Medicaid 63% · Health risk score 1.31. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 47% · Chronic kidney disease 28% · Coronary heart disease 21% · Heart failure 16% · Cancer 16%.
The office billed $46,409, Medicare allowed $27,471 and paid $17,599; for 199 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 68 | 199 | 78 | 1.31 | $46,409 | $17,599 |
| 2023 | 72 | 220 | 79 | 1.31 | $50,614 | $21,397 |
| 2022 | 81 | 237 | 78 | 1.30 | $52,215 | $21,048 |
| 2021 | 117 | 267 | 77 | 1.33 | $55,010 | $23,454 |
| 2020 | 73 | 199 | 77 | 1.39 | $35,199 | $16,517 |
| 2019 | 99 | 274 | 79 | 1.58 | $42,581 | $24,760 |
| 2018 | 111 | 327 | 77 | 1.45 | $54,871 | $30,815 |
| 2017 | 129 | 482 | 76 | 1.39 | $73,818 | $39,762 |
| 2016 | 149 | 425 | 74 | 1.39 | $70,102 | $36,253 |
| 2015 | 157 | 455 | 77 | 1.32 | $72,312 | $39,135 |
| 2014 | 202 | 524 | 74 | 1.27 | $95,335 | $49,404 |
| 2013 | 194 | 598 | 76 | 1.25 | $92,783 | $45,455 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 28 | $6,600 | $116 |
| Established patient complete exam of visual system | 42 | $5,105 | $100 |
| Established patient problem focused exam of visual system | 22 | $1,942 | $63 |
| New patient complete exam of visual system | 15 | $1,762 | $117 |
| Exam of visual field with extended testing | 15 | $434 | $27 |
| Imaging of optic nerve | 19 | $360 | $19 |
2022: 5 services
| Established patient problem focused exam of visual system | 32 | $6,359 | $72 |
| Established patient complete exam of visual system | 53 | $6,114 | $99 |
| New patient complete exam of visual system | 21 | $2,564 | $122 |
| Exam of visual field with extended testing | 18 | $963 | $42 |
| Imaging of optic nerve | 13 | $258 | $20 |
2021: 5 services
| New patient complete exam of visual system | 63 | $8,091 | $128 |
| Established patient problem focused exam of visual system | 36 | $7,081 | $75 |
| Established patient complete exam of visual system | 47 | $5,821 | $112 |
| Exam of visual field with extended testing | 19 | $1,112 | $46 |
| Imaging of optic nerve | 14 | $253 | $18 |
2020: 4 services
| Established patient problem focused exam of visual system | 32 | $7,054 | $79 |
| Established patient complete exam of visual system | 43 | $4,964 | $110 |
| New patient complete exam of visual system | 15 | $1,809 | $121 |
| Exam of visual field with extended testing | 17 | $1,049 | $48 |
2019: 4 services
| Established patient problem focused exam of visual system | 49 | $9,942 | $78 |
| Established patient complete exam of visual system | 61 | $7,262 | $99 |
| New patient complete exam of visual system | 33 | $3,989 | $121 |
| Exam of visual field with extended testing | 19 | $1,160 | $53 |
2018: 4 services
| Established patient problem focused exam of visual system | 64 | $12,300 | $75 |
| Established patient complete exam of visual system | 69 | $8,329 | $103 |
| New patient complete exam of visual system | 29 | $3,624 | $125 |
| Exam of visual field with extended testing | 21 | $1,158 | $48 |
2017: 5 services
| Established patient problem focused exam of visual system | 81 | $21,012 | $74 |
| Established patient complete exam of visual system | 81 | $8,232 | $97 |
| New patient complete exam of visual system | 24 | $2,472 | $103 |
| Exam of visual field with extended testing | 33 | $1,928 | $52 |
| Imaging of optic nerve | 12 | $263 | $22 |
2016: 4 services
| Established patient problem focused exam of visual system | 77 | $14,454 | $70 |
| Established patient complete exam of visual system | 98 | $9,691 | $94 |
| New patient complete exam of visual system | 38 | $4,300 | $113 |
| Exam of visual field with extended testing | 24 | $1,432 | $46 |
2015: 4 services
| Established patient problem focused exam of visual system | 88 | $17,169 | $73 |
| Established patient complete exam of visual system | 101 | $11,017 | $101 |
| New patient complete exam of visual system | 33 | $3,423 | $104 |
| Exam of visual field with extended testing | 27 | $1,830 | $52 |
2014: 6 services
| Established patient problem focused exam of visual system | 93 | $17,288 | $69 |
| Established patient complete exam of visual system | 121 | $11,856 | $93 |
| Removal of cataract with insertion of prosthetic lens | 11 | $8,099 | $579 |
| New patient complete exam of visual system | 54 | $5,812 | $108 |
| Exam of visual field with extended testing | 29 | $1,782 | $57 |
| Ultrasound scan to determine eye length and lens power | 15 | $584 | $28 |
2013: 7 services
| Established patient problem focused exam of visual system | 112 | $18,908 | $69 |
| Established patient complete exam of visual system | 119 | $12,567 | $101 |
| New patient complete exam of visual system | 45 | $4,445 | $99 |
| Exam of visual field with extended testing | 35 | $2,062 | $50 |
| Imaging of optic nerve | 39 | $955 | $24 |
| Ultrasound scan of cornea to determine thickness | 37 | $306 | $8 |
| Exam of visual field with intermediate testing | 15 | $261 | $17 |
Drugs they prescribed that Part D paid
$72,453
Pharmacies billed $72,453 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 245) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
69 generic and 176 brand-name prescriptions · $72,453 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 49 | $23,619 | $482 |
| Restasis | 16 | $19,983 | $1,249 |
| Simbrinza | 24 | $5,607 | $234 |
| Travoprost | 14 | $2,509 | $179 |
| Latanoprost | 54 | $582 | $11 |
See all 7 drugs
| Lumigan | 49 | $23,619 | $482 |
| Restasis | 16 | $19,983 | $1,249 |
| Simbrinza | 24 | $5,607 | $234 |
| Travoprost | 14 | $2,509 | $179 |
| Latanoprost | 54 | $582 | $11 |
| Dorzolamide | 12 | $221 | $18 |
| Brimonidine | 11 | $202 | $18 |
Year by year
| 2024 | 245 | 42 | 0% (0) | 72% | $72,453 |
| 2023 | 262 | 47 | 0% (0) | 78% | $69,177 |
| 2022 | 206 | 33 | 0% (0) | 81% | $68,196 |
| 2021 | 217 | 38 | 0% (0) | 79% | $58,539 |
| 2020 | 248 | 40 | 0% (0) | 75% | $56,672 |
| 2019 | 264 | 43 | 0% (0) | 75% | $52,877 |
| 2018 | 310 | 59 | 0% (0) | 75% | $54,086 |
| 2017 | 424 | 75 | 0% (0) | 72% | $56,319 |
| 2016 | 441 | 72 | 0% (0) | 69% | $48,909 |
| 2015 | 463 | 76 | 0% (0) | 79% | $49,679 |
| 2014 | 397 | 85 | 0% (0) | 77% | $41,764 |
| 2013 | 423 | 92 | 0% (0) | 80% | $49,654 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Restasis | 12 | $17,373 | $1,448 |
| Lumigan | 32 | $12,329 | $385 |
| Rocklatan | 19 | $7,440 | $392 |
| Simbrinza | 21 | $5,309 | $253 |
| Ilevro | 12 | $4,742 | $395 |
| Latanoprost | 82 | $1,740 | $21 |
2022: 8 drugs
| Restasis | 22 | $24,852 | $1,130 |
| Xiidra | 16 | $10,875 | $680 |
| Lumigan | 16 | $7,778 | $486 |
| Rocklatan | 15 | $6,048 | $403 |
| Vyzulta | 12 | $5,840 | $487 |
| Simbrinza | 19 | $5,047 | $266 |
| Travoprost | 11 | $1,774 | $161 |
| Latanoprost | 43 | $754 | $18 |
2021: 4 drugs
| Restasis | 39 | $28,809 | $739 |
| Lumigan | 43 | $17,766 | $413 |
| Simbrinza | 18 | $3,439 | $191 |
| Latanoprost | 49 | $953 | $19 |
2020: 7 drugs
| Restasis | 32 | $23,208 | $725 |
| Lumigan | 53 | $18,920 | $357 |
| Travatan Z | 13 | $3,728 | $287 |
| Travoprost | 21 | $3,459 | $165 |
| Dorzolamide-Timolol | 15 | $750 | $50 |
| Latanoprost | 44 | $629 | $14 |
| Dorzolamide | 11 | $236 | $21 |
2019: 6 drugs
| Restasis | 37 | $23,560 | $637 |
| Lumigan | 62 | $15,036 | $243 |
| Travatan Z | 25 | $5,243 | $210 |
| Zioptan | 11 | $2,314 | $210 |
| Latanoprost | 52 | $932 | $18 |
| Timolol Maleate | 11 | $91 | $8 |
2018: 8 drugs
| Restasis | 42 | $22,420 | $534 |
| Lumigan | 52 | $10,346 | $199 |
| Travatan Z | 40 | $7,546 | $189 |
| Latanoprost | 57 | $848 | $15 |
| Prednisolone Acetate | 16 | $476 | $30 |
| Dorzolamide-Timolol | 17 | $466 | $27 |
| Ketorolac Tromethamine | 12 | $266 | $22 |
| Timolol Maleate | 17 | $114 | $7 |
2017: 12 drugs
| Restasis | 32 | $17,068 | $533 |
| Lumigan | 68 | $11,321 | $166 |
| Travatan Z | 48 | $8,391 | $175 |
| Azopt | 17 | $4,738 | $279 |
| Pazeo | 19 | $3,168 | $167 |
| Latanoprost | 72 | $1,050 | $15 |
| Prednisolone Acetate | 21 | $957 | $46 |
| Dorzolamide-Timolol | 24 | $551 | $23 |
| Neomycin-Polymyxin-Dexameth | 19 | $316 | $17 |
| Ketorolac Tromethamine | 13 | $197 | $15 |
| Timolol Maleate | 19 | $176 | $9 |
| Erythromycin | 16 | $176 | $11 |
2016: 14 drugs
| Lumigan | 57 | $9,314 | $163 |
| Travatan Z | 47 | $8,324 | $177 |
| Restasis | 11 | $7,313 | $665 |
| Azopt | 19 | $5,403 | $284 |
| Pataday | 23 | $3,704 | $161 |
| Pazeo | 23 | $3,575 | $155 |
| Latanoprost | 69 | $959 | $14 |
| Prednisolone Acetate | 18 | $793 | $44 |
| Ketorolac Tromethamine | 24 | $506 | $21 |
| Dorzolamide | 17 | $323 | $19 |
| Timolol Maleate | 32 | $241 | $8 |
| Dorzolamide-Timolol | 14 | $208 | $15 |
| Neomycin-Polymyxin-Dexameth | 11 | $196 | $18 |
| Erythromycin | 15 | $173 | $12 |
2015: 9 drugs
| Lumigan | 104 | $15,826 | $152 |
| Azopt | 35 | $8,093 | $231 |
| Travatan Z | 57 | $7,805 | $137 |
| Pataday | 39 | $6,046 | $155 |
| Latanoprost | 71 | $1,012 | $14 |
| Ketorolac Tromethamine | 17 | $388 | $23 |
| Dorzolamide-Timolol | 22 | $380 | $17 |
| Erythromycin | 12 | $150 | $12 |
| Timolol Maleate | 11 | $79 | $7 |
2014: 9 drugs
| Lumigan | 94 | $13,877 | $148 |
| Pataday | 57 | $8,278 | $145 |
| Travatan Z | 30 | $3,541 | $118 |
| Nevanac | 16 | $2,674 | $167 |
| Latanoprost | 48 | $782 | $16 |
| Prednisolone Acetate | 15 | $740 | $49 |
| Dorzolamide-Timolol | 21 | $617 | $29 |
| Ketorolac Tromethamine | 17 | $367 | $22 |
| Neomycin-Polymyxin-Dexameth | 16 | $285 | $18 |
2013: 9 drugs
| Lumigan | 78 | $13,780 | $177 |
| Pataday | 90 | $11,457 | $127 |
| Travatan Z | 46 | $5,946 | $129 |
| Azopt | 22 | $2,931 | $133 |
| Bromday | 13 | $2,628 | $202 |
| Alphagan P | 11 | $1,907 | $173 |
| Dorzolamide-Timolol | 23 | $653 | $28 |
| Latanoprost | 40 | $639 | $16 |
| Timolol Maleate | 15 | $254 | $17 |
Money from drug and device companies
$109 in 2022
| 2022 | 1 | 1 | None | $109 |
| 2020 | 2 | 2 | None | $33 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Clareon | $109 | 1 payment
|
See the published payment
| Alcon Vision | Meals · 2022-10-25 | Clareon | $109 |
See earlier years (2020)
2020: $33
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
| Akorn | Zioptan | $14 | 1 payment
|
Professional record
- NPI
- 1558323360
- Licence
- CA G842181
- Trained
- New York University School of Medicine, 1992 · 34 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G842181
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 2186 Geary Blvd Ste 312, San Francisco, CA, 94115
- NPI first listed
- 2006-04-05
- NPI last updated
- 2018-09-26
This is when the NPI record was last certified, not a medical board exam.